drugset / Trial / NCT01035580
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this study is to determine the maximum tolerable dose and safety of intravaginal curcumin in a normal population of women (women with no evidence of cervical cytological abnormalities by pap testing).
Timeline
- Start
- 2010-01
- Primary completion
- 2011-04
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 500 mg | Other |
| Subject | Curcumin | Small molecule | 1000 mg | Other |
| Subject | Curcumin | Small molecule | 1500 mg | Other |
| Subject | Curcumin | Small molecule | 2000 mg | Other |